Your browser doesn't support javascript.
loading
User and Usability Testing of a Web-Based Genetics Education Tool for Parkinson Disease: Mixed Methods Study.
Han, Noah; Paul, Rachel A; Bardakjian, Tanya; Kargilis, Daniel; Bradbury, Angela R; Chen-Plotkin, Alice; Tropea, Thomas F.
Afiliação
  • Han N; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Paul RA; Department of Neurology, Pennsylvania Hospital, Philadelphia, PA, United States.
  • Bardakjian T; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Kargilis D; Department of Neurology, Pennsylvania Hospital, Philadelphia, PA, United States.
  • Bradbury AR; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
  • Chen-Plotkin A; Department of Neurology, Pennsylvania Hospital, Philadelphia, PA, United States.
  • Tropea TF; Sarepta Therapeutics, Cambridge, MA, United States.
JMIR Bioinform Biotechnol ; 4: e45370, 2023 Aug 30.
Article em En | MEDLINE | ID: mdl-38935961
ABSTRACT

BACKGROUND:

Genetic testing is essential to identify research participants for clinical trials enrolling people with Parkinson disease (PD) carrying a variant in the glucocerebrosidase (GBA) or leucine-rich repeat kinase 2 (LRRK2) genes. The limited availability of professionals trained in neurogenetics or genetic counseling is a major barrier to increased testing. Telehealth solutions to increase access to genetics education can help address issues around counselor availability and offer options to patients and family members.

OBJECTIVE:

As an alternative to pretest genetic counseling, we developed a web-based genetics education tool focused on GBA and LRRK2 testing for PD called the Interactive Multimedia Approach to Genetic Counseling to Inform and Educate in Parkinson's Disease (IMAGINE-PD) and conducted user testing and usability testing. The objective was to conduct user and usability testing to obtain stakeholder feedback to improve IMAGINE-PD.

METHODS:

Genetic counselors and PD and neurogenetics subject matter experts developed content for IMAGINE-PD specifically focused on GBA and LRRK2 genetic testing. Structured interviews were conducted with 11 movement disorder specialists and 13 patients with PD to evaluate the content of IMAGINE-PD in user testing and with 12 patients with PD to evaluate the usability of a high-fidelity prototype according to the US Department of Health and Human Services Research-Based Web Design & Usability Guidelines. Qualitative data analysis informed changes to create a final version of IMAGINE-PD.

RESULTS:

Qualitative data were reviewed by 3 evaluators. Themes were identified from feedback data of movement disorder specialists and patients with PD in user testing in 3 areas content such as the topics covered, function such as website navigation, and appearance such as pictures and colors. Similarly, qualitative analysis of usability testing feedback identified additional themes in these 3 areas. Key points of feedback were determined by consensus among reviewers considering the importance of the comment and the frequency of similar comments. Refinements were made to IMAGINE-PD based on consensus recommendations by evaluators within each theme at both user testing and usability testing phases to create a final version of IMAGINE-PD.

CONCLUSIONS:

User testing for content review and usability testing have informed refinements to IMAGINE-PD to develop this focused, genetics education tool for GBA and LRRK2 testing. Comparison of this stakeholder-informed intervention to standard telegenetic counseling approaches is ongoing.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article